Survey of tomotherapy for methotelioma in Japan: patterns of practice and clinical outcomes.

Survey of tomotherapy for methotelioma in Japan: patterns of practice and clinical outcomes. - Survey of tomotherapy for methotelioma in Japan: patterns of practice and clinical outcomes.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000042430

Enrollment

Registered

2020-11-13

Start date

2019-11-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant pleural mesothelioma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Underwent radicak radiation therapy using Tomotherapy (Including combined use of Tomotherapy and Linic). 2. Prescription dose is more tan 45Gy (Including cases did not reach the priscriotion dose). 3. Whether or not the tumor remains after surgery. 4. Whether or not chemotherapy is used in combination. 5. With or without surgical surgery (including preoperative irradiation and no surgery). 6. Stage III or less in TMN stage classification.

Exclusion criteria

Exclusion criteria: 1. Under 20 years of age during radiation therapy. 2. Cases had underwent radiation therapy to the chest 3. Histopathologically undetermined or unconscionable diagnosis

Design outcomes

Primary

Measure	Time frame
Overall survival	—

Countries

Japan

Contacts

Public ContactMikiko Imai

Nagoya City University Department of Radiology

nakanishi.ncu@gmail.com0528538276

Outcome results